István Molnár
Saarland University(DE)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Thyroid Cancer Diagnosis and Treatment, Acute Myeloid Leukemia Research, Monoclonal and Polyclonal Antibodies Research, Cancer Treatment and Pharmacology
Most-Cited Works
- → Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial(2014)1,610 cited
- → HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician’s choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer(2016)155 cited
- → Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia—retrospective study and review of literature(2004)120 cited
- → Safety and pharmacokinetics of MM-302, a HER2-targeted antibody–liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study(2018)119 cited
- → Copper deficiency causes reversible myelodysplasia(2007)94 cited
- → Sorafenib in locally advanced or metastatic patients with radioactive iodine-refractory differentiated thyroid cancer: The phase III DECISION trial.(2013)70 cited
- → Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)(2013)55 cited
- → Population Pharmacokinetics of Liposomal Irinotecan in Patients With Cancer(2017)54 cited
- → Intrapulmonary thrombin generation and its relation to monomethylmethacrylate plasma levels during hip arthroplasty(1992)50 cited
- → Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis(2013)50 cited